Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Veterans Affairs was posted on February 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6515--SOURCES SOUGHT - 3D Bioprinter for Research Project for the Iowa City VA Healthcare System

Closed
36C26326Q0348Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is establishing the Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. This continuous, open announcement seeks to build a network of pre-qualified partners to accelerate the development, testing, and fielding of next-generation medical defense solutions. The program focuses on two primary pillars: host-targeted resilience, which targets critical host systems like neurological and respiratory pathways to enhance physiological protection, and threat-targeted neutralization, which focuses on broad-spectrum countermeasures for prophylaxis and acute treatment. Priority is given to candidates designed for austere environments, featuring environmental stability without cold-chain reliance and simplified administration routes such as oral or intranasal delivery. The government is inviting two types of participants: MCM Development Collaborators, ranging from Phase I products through FDA licensure, and MCM Development Support Collaborators, such as CROs and CDMOs specializing in preclinical testing, cGMP manufacturing, and regulatory submissions. Interested parties must submit a white paper of no more than five pages detailing their product descriptions, efficacy data, regulatory status, and manufacturing capabilities. Acceptance into the PBA enables the subsequent award of project orders under the authority of 10 U.S.C sections 4021, 4022, and 4023. These agreements are not subject to the Competition in Contracting Act of 1984. All prospective awardees must be registered in the System for Award Management (SAM) database to receive payment.
W6QK Acc-Apg

POSTED

about 7 hours ago

DEADLINE

N/A
NAICS: 541714
New
Federal
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Solicitation # FDABAA-27-00123
The FY27 FDA Broad Agency Announcement (FDABAA-27-00123) solicits basic and applied research and development proposals to advance regulatory science and innovation. Managed by the FDA Office of Acquisitions and Grants Services, this solicitation is open to all responsible sources, including small businesses and academic institutions. The program focuses on 22 priority research areas, with recent updates adding specific interests in human tooth enamel evaluation techniques for anticaries dentifrice products and the adoption of Super Intelligence terminology in tobacco and nicotine research per Executive Order 14434. Interested parties must follow a two-tiered submission process consisting of a three-page concept paper and a comprehensive full proposal, which includes a technical volume limited to 50 pages and a detailed cost proposal. All applications must be submitted as searchable PDFs via email by January 22, 2027, at 5:00 PM EST. A virtual BAA Day is scheduled for December 8, 2026, to provide guidance on the application process and FDA priorities. Awards are based on the overall best value to the government, evaluated through a high-level relevance review followed by a technical review by subject matter experts. Successful offerors must comply with Good Manufacturing Practice Regulations (21 CFR Parts 210-211) and other relevant biological or diagnostic standards. Additionally, proposals exceeding $900,000 from non-small businesses require a Small Business Subcontracting Plan. Contractors must also warrant the absence of organizational conflicts of interest and adhere to strict data disclosure and privacy regulations.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 2 months
NAICS: 541714
New
Federal
Presolicitation Notice to Sole Source for Experimental Pathology Laboratories, Inc. (EPL)
Solicitation # Presolicitation_NOI_Sole_Source_EPL
The U.S. Environmental Protection Agency, through the Office of the Chief Procurement Officer's Water, Tribal, and Science Division, intends to award a firm-fixed price purchase order for histology and pathology services of maternal and neonatal rodent specimen organs. The work will be performed at the EPA Headquarters in Washington, DC, and focuses on the toxicologic pathology of environmental contaminants, including PFAS, phthalates, air pollutants, and endocrine-disrupting compounds. This acquisition is intended to continue existing larger studies to maintain data integrity and avoid protocol deviations. The EPA intends to sole source this requirement to Experimental Pathology Laboratories, Inc. (EPL) due to their specialized experience with environmental contaminants, compliance with Good Laboratory Practice regulations, and their ability to accept hand-delivered samples as a local vendor. The procurement falls under NAICS code 541714 for Research and Development in Biotechnology and PSC code AZ11. While the agency intends to award to EPL, other responsible sources may submit capability statements, proposals, or quotations by November 30, 2026. The estimated award date is December 3, 2026. All vendors must maintain a public profile in the System for Award Management and utilize the FedConnect portal for contract communications.
Tribal & Science Division Water

POSTED

4 days ago

DEADLINE

in 13 days
NAICS: 541714
New
Federal
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Solicitation # ARPA-H-SOL-26-164
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program under solicitation ARPA-H-SOL-26-164. This five-year initiative aims to create a reusable blueprint for future adaptive seamless platform trials through the integration of three technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations. The program is divided into two stages, with Stage I focusing on capability buildout, FDA engagement, and the onboarding of at least three intervention arms over 24 months, followed by a 36-month Stage II dedicated to validation and deployment. A critical go/no-go milestone is obtaining FDA authorization for the platform Master Protocol IND and at least one investigational arm by the end of Stage I. The government intends to make multiple awards via Other Transaction Agreements to proposers offering the most advantageous solutions based on innovation, feasibility, and technical merit at reasonable prices. Eligible entities must possess a Unique Entity Identifier and active SAM registration. Proposals are submitted in a phased approach, beginning with a Solution Summary and potentially progressing to a Solution Pitch package. Performance will be measured by the successful integration of the three technical areas and the achievement of specific program metrics. All work must adhere to ICH E6(R3) Good Clinical Practice and strict regulatory standards to ensure inspection readiness and participant safety.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

4 days ago

DEADLINE

in 13 days
NAICS: 541714
New
Federal
Laguna Industry Day
Solicitation # DARPA-SN-27-18
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is hosting a virtual Industry Day on December 9, 2026, for the Laguna program under Special Notice DARPA-SN-27-18. The program's primary objective is to develop and demonstrate integrated manufacturing approaches that convert abundant domestic feedstocks, such as sugars, ethylene, and BTX, into application-ready specialty chemical formulations. By minimizing intermediate processing steps and separations, the initiative seeks to reduce reliance on vulnerable foreign supply chains. The anticipated 36-month effort is divided into two technical areas: Make and Formulate, which focuses on developing defense-relevant specialty products from U.S. raw materials, and Model, which aims to create predictive tools to optimize the relationship between feedstocks, synthesis, and final product performance. This notice is issued for information and program planning purposes and does not constitute a formal solicitation for proposals. Interested parties must register for the Industry Day event by December 2, 2026. The program requires that resulting products meet or exceed the performance of current military materials, with deliverables including technoeconomic analyses, life cycle assessments, and commercialization strategy plans. Technical and administrative inquiries are managed by Dr. William Mounfield and can be directed to [email hidden]. A draft program solicitation is expected to be released on sam.gov prior to the Industry Day event.
Defense Advanced Research Projects Agcy

POSTED

5 days ago

DEADLINE

in 15 days

General Info

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Dept. of Veterans Affairs Iowa City VA Healthcare System, Iowa City, IA, 52246, USA

Set-Aside

NONE

Documents

2
DOCX, High priority: read this first3 pages · sources-sought
High
DOCX, Low priority4 pages · sources-sought
Low

Read all 2 documents

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)Open now
  • Clinical Research Site Operations and Participant ManagementOpen now, due in 9 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Network Contract Office 23 (36C263)
Contacts1 person available
OfficeSaint Paul, MN, 55101, USA

Full Description

Show more
REQUEST FOR INFORMATION / SOURCES SOUGHT: 36C26326Q0348
This is NOT a solicitation.
SUBJECT: 3D Bioprinter for the Department of Veterans Affairs, Iowa City VA Healthcare System Research Department.
NAICS CODE: 541350, Size Standard: 1000 employees. PSC: 6515
All responses must have the VA RFI Number: 36C26326Q0348 in the Subject Line of the email!!! All responses must be received no later than 11:59 PM CT, Friday, February 20, 2026 All responses must be submitted to: Sign up to see this detail.
See Attached: 36C26326Q0348 Sources Sought 3D BioPrinter Iowa City VA Healthcare System

More opportunities from Department Of Veterans Affairs → Network Contract Office 23 (36C263)

Same awarding agency

NAICS: 621511
New
Federal
NWI Offsite Pathology Services
Solicitation # 36C26326R0063
The Department of Veterans Affairs, Nebraska-Western Iowa Health Care System, is soliciting a Fixed Price, Indefinite Delivery, Indefinite Quantity (IDIQ) contract for offsite medical laboratory, pathology, and testing analysis services. The selected contractor will be responsible for pre-analytic processing, analysis, and reporting of clinical and anatomical pathology specimens, including the provision of all necessary personnel and specialized collection and transportation supplies. While the VA handles most specimen collection and preparation, the contractor is responsible for grossing global surgical pathology cases and must return all slides and blocks to the VA for permanent storage. The contract features a five-year ordering period beginning April 1, 2027, with a total small business set-aside. Award will be based on the Lowest Priced Technically Acceptable (LPTA) quote, with technical acceptability contingent upon CAP, Joint Commission, and CLIA accreditations, as well as a review of past performance from the previous five years. The contractor must adhere to strict quality standards outlined in the Quality Assurance Surveillance Plan, including a 100 percent accuracy rate for specimen labeling and specific turnaround times for cytology and autopsy reports. Key requirements include compliance with HIPAA, the Privacy Act, and hazardous materials regulations for transporting biological substances. The contractor must also maintain specific insurance coverages, including general liability and employer's liability, and ensure all personnel undergo background investigations per VA security standards.
Medical Laboratories

POSTED

about 7 hours ago

DEADLINE

in 13 days
View Details
NAICS: 513120
New
Federal
Minneapolis VA Medical Library Serials & Periodicals Solicitation
Solicitation # 36C26327Q0008
Solicitation 36C26327Q0008 is a small business set-aside request for quotations issued by the Department of Veterans Affairs, Network Contracting Office 23, to provide periodical and serial subscriptions for the Minneapolis VA Health Care System. The scope of work includes the management and provision of databases, e-books, e-journals, and point-of-care online services. Key deliverables include the delivery of catalog data in MARC format and the provision of authorization letters from each Original Equipment Manufacturer to prevent the procurement of gray market or counterfeit items. The contract period of performance is established from January 1, 2027, through December 31, 2027, with an option to extend services for up to six additional months. The government will utilize the Lowest Price Technically Acceptable process for award, evaluating offers based on a capability narrative and a fixed-price quote. Following five amendments, the number of line items was reduced from 47 to 10, and the final offer deadline is November 27, 2026, at 17:00 Central Time. Submissions must be sent electronically and divided into two volumes: Volume I for pricing and administrative forms, and Volume II for the technical capability narrative and past performance references. Performance will support various duty stations, including the Minneapolis VAMC and several clinics across Minnesota and Wisconsin.
Periodical Publishers

POSTED

4 days ago

DEADLINE

in 10 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS